MEDICINOVA INC·4

Jan 20, 5:04 PM ET

Matsuda Kazuko 4

4 · MEDICINOVA INC · Filed Jan 20, 2026

Insider Transaction Report

Form 4
Period: 2026-01-16
Matsuda Kazuko
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    [F1]
    2026-01-16+350,000350,000 total
    Exercise: $2.10From: 2026-01-16Exp: 2035-01-06Common Stock (350,000 underlying)
Footnotes (1)
  • [F1]On January 7, 2025, the reporting person was granted an option to purchase 350,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Such performance criteria for 2025 were met, resulting in full vesting of the option.
Signature
/s/ Yuichi Iwaki, attorney-in-fact|2026-01-20

Documents

1 file
  • 4
    ownership.xmlPrimary